Xu et al. created insulin-SLN containing endosomal peptides which showed that oral injection of this insulin-SLN reduced blood glucose levels in diabetics by almost 35% following 3 h and by nearly 20% upon 12 h. The gene discussed is INS; the disease is diabetes mellitus.